Want 131% to 143% Gains? 2 Tech Stocks to Buy, According to Wall Street
Many investors are preoccupied with soaring inflation. The consumer price index jumped 7.9% in February, marking its fastest growth since January 1982, according to the U.S. Labor Department. Of course, rising prices tend to curtail consumer spending, which negatively impacts corporate revenue growth. As a result, many stocks have sold off sharply in recent months, and the S&P 500 is currently in correction territory.
Despite the macroeconomic environment, some of Wall Street's finest stock pickers see significant near-term upside for certain companies. For instance, Oppenheimer analysts Jason Helfstein has a price target of $45 of Lemonade (NYSE: LMND), implying 143% upside. Similarly, Oppenheimer analyst Brian Schwartz has a price target of $56 on UiPath (NYSE: PATH), implying 131% upside. Clearly, these investing professionals see something they like in both companies, so let's take a closer look.
Here's what you should know.
Source Fool.com
